Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 04, 2022

SELL
$20.49 - $39.72 $2,049 - $3,972
-100 Reduced 4.35%
2,200 $1,000
Q1 2022

Apr 14, 2022

BUY
$28.19 - $46.6 $42,285 - $69,900
1,500 Added 187.5%
2,300 $9,000
Q4 2020

Jan 21, 2021

BUY
$41.43 - $77.09 $4,143 - $7,709
100 Added 14.29%
800 $2,000
Q2 2020

Jul 22, 2020

BUY
$18.95 - $35.43 $7,580 - $14,172
400 Added 133.33%
700 $2,000
Q2 2019

Aug 09, 2019

BUY
$25.78 - $39.77 $5,156 - $7,954
200 Added 200.0%
300 $2,000
Q3 2018

Nov 07, 2018

BUY
$12.1 - $28.85 $1,210 - $2,885
100 New
100 $1,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.31B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.